[Abstract] Pravastatin and Rosiglitazone May Attenuate Coronary Artery Disease by Decreasing Interferon-gamma, Tumor Necrosis Factor- alpha, Interleukin-6, Macrophage Chemotactic Protein-1, C-Reactive Protein, and Increasing Interleukin-4

L. G. Tan, S. A. Tan, Lee Berk

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageAmerican English
Title of host publicationNew Horizons in Coronary Artery Disease - Proceedings of the 7th International Congress on Coronary Artery Disease
StatePublished - 2007

Disciplines

  • Cardiovascular Diseases
  • Medical Pathology
  • Medical Physiology

Cite this